Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 13.50p on 20-03-2026 at 05:12:27
Change 0.00p 0%
Buy 14.00p
Sell 13.00p
Last Trade: Unknown 50,000.00 at 13.16p
Day's Volume: 0
Last Close: 13.50p
Open: 0.00p
ISIN: VGG042401262
Day's Range 0.00p - 0.00p
52wk Range: 7.00p - 29.00p
Market Capitalisation: £6.98m
VWAP: 0.00p
Shares in Issue: 51.74m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 50,000 13.16p Ordinary
15:01:37 - 19-Mar-26
Buy* 36,493 13.69p Ordinary
15:00:15 - 19-Mar-26
Buy* 114 14.00p SI Trade
12:49:45 - 19-Mar-26
Buy* 229 14.00p SI Trade
12:49:45 - 19-Mar-26
Buy* 80 14.00p SI Trade
12:49:45 - 19-Mar-26
Sell* 884 13.00p SI Trade
12:49:45 - 19-Mar-26
Buy* 31 14.00p SI Trade
12:49:45 - 19-Mar-26
Buy* 172 14.00p SI Trade
12:49:45 - 19-Mar-26
Buy* 64 14.00p SI Trade
12:49:45 - 19-Mar-26
Buy* 714 14.00p SI Trade
12:49:45 - 19-Mar-26
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Mar 2026 (Fri) 13.50 13.50 13.50 13.50 0
19th Mar 2026 (Thu) 13.75 13.75 13.50 13.50 226,504
18th Mar 2026 (Wed) 14.50 14.50 13.75 13.75 375,025
17th Mar 2026 (Tue) 12.50 14.50 12.50 14.50 2,234,227
16th Mar 2026 (Mon) 11.75 12.00 11.75 12.00 208,195
13th Mar 2026 (Fri) 12.00 12.00 11.75 11.75 87,119
12th Mar 2026 (Thu) 12.00 12.00 12.00 12.00 5,445
11th Mar 2026 (Wed) 12.00 12.00 12.00 12.00 396
10th Mar 2026 (Tue) 12.00 12.00 12.00 12.00 294,134
9th Mar 2026 (Mon) 12.50 12.50 12.00 12.00 123,345
6th Mar 2026 (Fri) 13.00 13.00 12.25 12.50 222,362
5th Mar 2026 (Thu) 12.00 13.00 12.00 13.00 580,143
4th Mar 2026 (Wed) 11.25 12.00 11.25 12.00 198,136
3rd Mar 2026 (Tue) 13.25 13.25 10.75 11.25 625,380
2nd Mar 2026 (Mon) 13.75 13.75 13.25 13.25 187,261
27th Feb 2026 (Fri) 14.50 14.50 13.75 13.75 375,044
26th Feb 2026 (Thu) 14.75 15.00 14.50 14.50 278,017
25th Feb 2026 (Wed) 15.00 15.00 14.50 14.75 201,998
24th Feb 2026 (Tue) 15.00 15.00 15.00 15.00 133,317
23rd Feb 2026 (Mon) 17.25 17.25 15.00 15.00 630,697
20th Feb 2026 (Fri) 17.50 17.50 17.25 17.25 281,507
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
17th Mar 2026 7:00 am RNS Awarding of Orphan Drug Designation by the FDA
17th Mar 2026 7:00 am RNS Awarding of Orphan Drug Designation by the FDA
20th Jan 2026 7:00 am RNS Japanese Patent Grant
9th Jan 2026 7:00 am RNS Results of Shareholder Analysis
15th Dec 2025 2:29 pm RNS Result of Retail Offer
10th Dec 2025 7:25 am RNS Retail Offer
10th Dec 2025 7:00 am RNS Placing of £1,000,000
27th Nov 2025 7:00 am RNS Holding(s) in Company
30th Oct 2025 7:00 am RNS US Orphan Drug Designation Application
14th Oct 2025 7:00 am RNS Positive Preclinical Data in Prostate Cancer
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss

17th Mar 2026 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million

10th Dec 2025 16:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

CRISM reports "significant" preclinical data for prostate cancer drug

14th Oct 2025 16:50

(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substantially enhance" the efficacy of docetaxel in the treatment of prostate cancer. Read More

EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial

15th Sep 2025 21:41

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval

26th Aug 2025 13:56

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - As the firm held its annual general meeting, Chair Nermeen Varawalla says the firm must attract, retain and incentivise the best people as it continues to seek further validation for its novel delivery method. "[We] are confident that ChemoSeed has the potential to transform treatment for patients with solid-tumour cancers," Chair Varawalla continues. ChemoSeed is an implantable biodegradable drug delivery technology designed for the sustained delivery of chemotherapy directly into cancer tissue. Chair Varawalla says the company is focused on gaining trial approval from the UK Medicines & Healthcare products Regulatory Agency in glioblastoma and progressing towards dosing first patients in early 2026. Read More

See more Crism Thera news
FTSE 100 Latest
Value10,063.50
Change-241.79

Login to your account

Forgot Password?

Not Registered